/VIRS
VIRS Stock - Pacer BioThreat Strategy ETF
Financial Services|Asset ManagementCBOE
$40.02+0.03%
+$0.01 (+0.03%) • Oct 10
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.69
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.83
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $44.03
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VIRS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$39.62 – $40.43
TARGET (TP)$46.03
STOP LOSS$36.82
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.92
52W High$40.03
52W Low$30.30
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. It is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
VIRSLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about VIRS
What is VIRS's current stock price?
Pacer BioThreat Strategy ETF (VIRS) is currently trading at $40.02 per share. The stock has moved +0.03% today.
What is the analyst price target for VIRS?
No analyst price targets are currently available for this stock.
What sector is Pacer BioThreat Strategy ETF in?
Pacer BioThreat Strategy ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the CBOE exchange.
What is VIRS's market cap?
Pacer BioThreat Strategy ETF has a market capitalization of $0.00 billion, making it a small-cap company.
Does VIRS pay dividends?
No, Pacer BioThreat Strategy ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBNE
Blue Horizon BNE ETF
$22.49
Mkt Cap: $0.0B
DCAP
Unity Wealth Partners Dynamic Capital Appreciation & Options ETF
$21.11
Mkt Cap: $0.0B
DSOC
Innovator Double Stacker ETF – October
$32.33
Mkt Cap: $0.0B
INNO
Harbor Disruptive Innovation ETF
$17.72
Mkt Cap: $0.0B
IVEG
iShares Emergent Food and AgTech Multisector ETF
$21.65
Mkt Cap: $0.0B
MTVR
Fount Metaverse ETF
$17.53
Mkt Cap: $0.0B
NSPY
NightShares 500 ETF
$29.55
Mkt Cap: $0.0B
QQC
Simplify Nasdaq 100 plus convexity ETF
$24.46
Mkt Cap: $0.0B
RORO
ATAC US Rotation ETF
$16.35
Mkt Cap: $0.0B
URAX
Defiance Daily Target 2X Long Uranium ETF
$7.94
Mkt Cap: $0.0B
Explore stocks similar to VIRS for comparison